Real-World Evidence Cases Cases > Real-World Evidence How we’ve helped other companies with registry data Browse the articles below to see how we helped other pharmaceutical companies improve their market positioning with health registry studies. If you’re interested in a different service area, visit our curated collection of cases within Market Access, Advanced Market Research, and Sales Performance. Improving ADHD treatment strategies with real-world data Real-World Evidence Medice Nordic Denmark Resource optimization Inspire me RWE study reveals sustained efficacy of diabetes treatment Real-World Evidence Danish health registries Peer-reviewed findings Inspire me Forecasting trends to drive vaccination uptake in Denmark Real-World Evidence Private market disparities 10 years forecast Inspire me RWD reveals gaps in advanced breast cancer care Real-World Evidence Improved resource planning Better access to care Inspire me Trends in medical treatment for ADHD among Danish incident patients based on real-world data Real-World Evidence Medice Nordic Denmark Patterns differ by sex and age Inspire me Medical adherence to glaucoma treatment Real-World Evidence AbbVie 30k+ patients studied over 10 years Inspire me About Signum Signum empowers life science companies in the Nordics to turn complex data into clear business decisions. With access to the most comprehensive pharmaceutical sales data in the region, we provide trusted insights in areas such as Real-World Evidence, Market Access, Market Insights, Sales Performance, and HCP engagement. Our team of 60+ specialists has been a reliable partner to the Danish pharmaceutical industry for nearly 50 years as part of Lif, the Danish Association of the Pharmaceutical Industry. Today, we continue to build on that legacy with local offices in Norway and Sweden, as well as strategic partnerships in Finland, to deliver trusted consulting and data solutions across the Nordics. For more information, please contact Anne Cathrine Falch-Jørgensen Head of Nordic Real-World Evidence acfj@signumlifescience.com +45 61 776 975
